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An Open label, Randomised Controlled trial on the effectiveness of the Orve+ Wrap® versus Forced 
Air Warming in restoring normothermia in the Post Anaesthetic Care Unit. 
 
Abstract: 
Aims and objectives  
This study aims to determine the clinical effectiveness and safety of the Orve+Wrap® thermal 
blanket.   
Background  
Inadvertent peri-operative hypothermia is a common problem in Post Anaesthetic Care Units and 
can have significant effects on patients’ post-operative morbidity. Despite its commercial availability 
there is no clinical evidence on the effectiveness of Orve+Wrap®.  
Design 
A single centre prospective, open label, non-inferiority randomized controlled trial. 
Methods  
Post-operative hypothermic (35.0°C – 35.9°C) patients who had undergone elective surgery were 
randomised to receive either Orve+Wrap® or Forced Air Warming for the during their PACU stay. 
Patient temperatures we recorded every 10 minutes using Zero Heat Flux Thermometry. This study 
is reported using CONSORT Extension checklist for non-inferiority and equivalence trials.  
Results  
Between December 2016 and October 2018, 129 patients were randomised to receive either 
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post-operative temperature of patients receiving Orve+wrap® blanket was 36.2°C and 36.3°C for the 
patients receiving Forced Air Warming. The predefined non-inferiority margin of a mean difference 
in temperature of 0.3°C, was not reached between the groups at 60 minutes. Additionally, there 
were no statistical differences between adverse event rates across these groups.   
Conclusions 
In the context of this study warming patients with the Orve+wrap® was non-inferior to Forced Air 
Warming. There were comparable rates of associated post-operative consequences of warming 
(shivering, hypotension, arrhythmias or surgical site infections), between the groups.  
Relevance to clinical practice 
The Orve+wrap® potentially provides an alternative warming method to Forced Air Warming for 
patients requiring short term post-operative warming. However, there are still a number of 
unknowns regarding the Orve+wrap® performance and further exploration is required.  
This study was prospectively registered on the ISCRTN database (ISRCTN11563874). 
Keywords: Body Temperature; Orthopaedics; Post-Operative Care; Postoperative Sequelae; 
Randomised Controlled Trials; Temperature Measurement.  
Main Text  
 
Introduction 
Inadvertent peri-operative hypothermia, core temperature below 36°C, remains a common 
occurrence in clinical practice (National Institute for Health and Care Excellence [NICE], 2008; 
Karalapillai et al. 2013). In addition, NICE guidance (2008) recommends targeting a normal 
temperature range of between 36.5°C and 37.5°C for adult patients, except when otherwise 
clinically indicated. 
 
The risk of developing inadvertent peri-operative hypothermia varies widely (Alderson et al., 2014; 
Al-Qahtani & Messahel, 2014; Harper et al., 2008) but has been found to be as high as 73.5% in a 
cohort of Orthopaedic patients (Kiekkas et al., 2005). It is precipitated by exposure of the skin and 
internal organs, ambient use of fluids and gases; combined with the use of sedatives and anaesthetic 
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include the elderly, patients with cancer and chronic conditions, burn victims and patients with 
thyroid dysfunction (Warttig et al., 2014). 
The sequelae of peri-operative hypothermia can result in an increased morbidity (Billeter et al., 
2014), including cardiac complications (Sessler, 2001), higher blood transfusion rates (Rajagopalan et 
al., 2008) and the delaying of wound healing leading to increased risk of surgical site infections 
(Melling et al., 2001). 
Whilst avoidance of hypothermia is desirable, it is often difficult to achieve. Therefore, the 
institution of techniques to rewarm the patient promptly are essential to minimize potential 
complications, whilst at the same time ensuring interventions are well tolerated and effective. 
 
Background 
There are two different approaches to rewarming. Active warming; comprising of the application of 
an external heat source i.e. Forced Air Warming (FAW) and underbody resistive heating. 
Alternatively, passive rewarming consists of thermal insulation, whereby the heat generated from 
the patient is conserved to enable rewarming to occur i.e. additional cotton blankets or reflective 
blankets. Currently two Cochrane systematic reviews (Alderson et al., 2014, Warttig et al., 2014) 
found no clear evidence of the warming effects of thermal insulation on core temperature during 
surgery or in the post-operative period resulting in advocating the use of Forced Air Warming. 
   
One new passive warming device is the Orve+wrap® thermal insulation blanket (Orvecare®, Kingston 
Upon Hull, UK) (Figure 1).   The Orve+wrap® is a Class I medical device, comprised of a foil blanket in 
combination with a fleece lining. Under laboratory conditions it has demonstrated the ability to 
absorb and retain heat providing effective insulation [Data on file]. The Orve+wrap® blanket can be 
used from ambient temperature or prewarmed in a blanket warmer and the manufacturers 
currently advocate its use in pre-hospital, hospital, survival and veterinary applications. There are 
currently no randomised controlled trials on the effectiveness of the Orve+wrap® in a clinical 
environment or direct comparisons against other warming devices. 
 
With a paucity of evidence of the Orve+wrap’s® clinical performance, an assessment of the 
Orve+wrap’s® predicted performance is based on the balance of laboratory data supplied by the 
manufacturer [Data on file] and the results of a Cochrane review (Alderson et al., 2014), which 
highlighted 0.5 -1.0°C higher mean temperatures in patient who received  Forced Air Warming 
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important difference between patient’s temperatures at 60 minutes for patients receiving either the 
Orve+wrap® or Forced Air Warming. 
 
Methods 
We conducted a single centre, parallel design, stratified, open label, non-inferiority, randomised 
controlled trial. The protocol was reviewed by the National Research and Ethics Service, (XXXXXX 
committee (XX/XX/XXXX) and registered on the ISCRTN database (ISRCTN11563874). In addition, 
patient and public review of the protocol was undertaken by the Trans Humber Consumer Research 
Panel.  
 
The study was performed at Hospital, Town (blinding requested for peer review), United Kingdom 
between December 2016 and October 2018. Adult patients (≥16 years) planned for major (>90 
minutes) surgery were screened from elective theatre lists, initially from 8 Orthopaedic and latterly 3 
Cardiothoracic surgeons. Patients were excluded if they were unable to provide informed consent, 
had known thyroid dysfunction, already participating in a conflicting research study and unable to 
understand English language.  
 
Post-surgery, immediately on admission to a Post Anaesthetic Care Unit (PACU), a non-invasive Zero 
Heat Flux (ZHF) temperature sensor (SpotOn™, 3M, Bracknell, UK) was used to measure the patients’ 
temperature (after a period of sensor stabilisation), with placement on the patient’s lateral 
forehead. The patient’s corresponding tympanic temperature (Genius 3, Cardinal Health, Dublin) 
was also taken as part of standard care. 
Patients were randomised to receive either a warmed Orve+wrap® blanket or a Forced Air Warming 
blanket, if their temperature was between 35.0°C and 35.9°C. Patients outside of this temperature 
range were managed as per normal local practice and not randomised into the study. 
Randomisation occurred on a 1:1 basis, using permuted blocks of 4, 6 and 8 with stratification for 
age (16 to 64 years and ≥65 years) and anaesthesia type (General and Spinal ± sedation) via a web-
based generation software (Sealed Envelope™, London, UK) and was performed by a Research Nurse 
at the bedside. 
Post randomisation, patients in the intervention group received an Orve+wrap® blanket directly to 
the skin that had been warmed in a blanket warmer (Kingfisher, LTE Scientific, Oldham) set at 50°C, 
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Patients in the control arm were warmed using either a Warm Touch™ WT 6000 or Warm Touch™ 
5300 warming unit (Covidien, Minneapolis, USA) with a Warm Touch™ full body warming blanket 
(Covidien, Minneapolis, USA) and covered with a single cotton sheet. 
Patients then had their temperature recorded every 10 minutes with the ZHF thermometry and 
tympanic probe, up to and including discharge from PACU. Any evidence of shivering, clinically 
significant hypotension and bradycardia, new arrhythmias and bleeding were identified and 
recorded as adverse events. 
Ambient PACU temperature was recorded for the duration of the PACU stay for all randomised 
patients using a calibrated LogTag® TRID30-7 (LogTag®, Auckland, New Zealand). All temperature 
measurement devices were regularly maintained and calibrated throughout the course of the study 
in line with existing organisational procedures. 
At discharge from PACU to ward based care, all subsequent treatments were at the discretion of the 
ward-based team. Patients were followed up until 7 days post-surgery or discharge from hospital; 
whichever occurred first.   
The primary objective of this study was to determine whether the Orve+wrap
®
 was non inferior to 
Forced Air Warming when warming hypothermic patients. The primary outcome measure was mean 
temperature difference at 60 minutes post PACU admission. Secondary outcomes included PACU 
and hospital length of stay and the prevalence of all the adverse events including the severity of any 
post-operative shivering, which was graded 0-4 using Crossley and Mahajan’s shivering assessment 
tool, (1994). 
There are limited contemporaneous studies exploring thermal insulation blankets against a Forced 
Air Warming device. In calculating the sample size, we used local unpublished temperature audit 
data indicating a standard deviation of 0.5, a non-inferiority limit of 0.3°C was set based on what was 
deemed to be clinically relevant. A power analysis was conducted which determined that 102 
patients (51 per group) were required to ensure that the lower limit of the confidence interval about 
the mean difference between the two groups, fell within the 95% confidence interval of zero. In 
addition, we accounted for a potential 25% drop out of randomised patients who fail to reach the 60 
minutes primary outcome point in PACU due to; return to theatre, subsequent admission to critical 
care, refusal to use the blanket or withdrawal of consent.  In total we aimed to randomise 128 
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The primary outcome was patient body temperature which was measured at 10-minute intervals 
post PACU admission. It was planned that the key dependent variable would be patients’ 
temperature at 60 minutes. However, it was recognised that temperature on admission to PACU 
could influence the temperature at 60 minutes, therefore admission temperature was treated as a 
covariate. Accordingly, analysis using ANCOVA was used to account for this admission temperature 
covariate, when comparing Orve+wrap® with Forced Air Warming.   
Chi-squared tests were used to compare the categorical data between groups for the adverse 
events. A p-value <0.05 was used to indicate statistical significance. Statistical analyses were 
performed using SPSS (Version 22, IBM, Portsmouth, UK). This study is reported using the 
Consolidated Standards of Reporting Trials (CONSORT) Extension checklist for non-inferiority and 
equivalence trials (See Supplementary File 1). 
 
Results  
Five hundred and three patients were assessed for suitability for the study from which 281 
consented to participate (see Figure 2), 
One Hundred and Twenty-Nine patients were randomized into the two groups. However, one 
patient was excluded from analysis due to the retrospective identification of pre-existing thyroid 
dysfunction. The split between surgical specialties was 96% (n=123) Orthopaedic and 4% (n= 5) 
Cardiothoracic. The patients’ baseline characteristics are displayed in Table 1. 
The crude mean difference in temperature at each of the 10 minutes intervals for the first 60 
minutes is shown is Figure 3, with this difference between the groups remaining within 0.1°C, 
throughout the first hour of observations. 
Patient mean temperatures at 60 minutes post warming device placement between Orve+wrap® 
(n=30) with Forced Air Warming (n=32), when adjusted for patients’ temperature on arrival to PACU, 
showed no statistical difference (p=0.748) between the mean differences (Table2). Furthermore, 
Figure 4 demonstrates the mean difference of 0.040°C and the associated 95% Confidence intervals 
(CI :0.206,0.286) in relation to the predefined non inferiority margin.  
Regarding the safety aspects of the devices during patients’ PACU stay there was a low instance of 
issues observed, with post-operative shivering the most common. There was no statistical difference 
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demonstrated a statistically shorter length of PACU stay for those patients who received 
Orve+wrap® post operatively, 67.3 mins (22.59) vs 80.2 (44.36). This however did not translate to a 
shorter post-surgery length of hospital stay. The application of the warming device was slower in the 
Forced Air Warming group, with the time taken to place the Forced Air Warming device being 
significantly longer from the point at which the baseline Spot On™ temperature demonstrated 
hypothermia (Table 5). This translated into a statistically significant (p=<0.001) overall longer 
duration for Forced Air Warming device placement from admission into PACU.  
 
Discussion 
This study represents the first direct comparison of the Orve+ wrap® in a randomized controlled trial 
against any other warming device. The study is unique in that it compares a new passive warming 
blanket with Forced Air Warming, which Alderson et al (2014) describe as the current advocated 
“gold standard” treatment for post-operative hypothermia.  
For the primary outcome, the predefined non inferiority criteria, of a temperature difference of less 
than 0.3°C at 60 minutes, was observed. However, due to the insufficient number of patients who 
had evaluable data at the 60 minutes timepoint and based on our power calculator, there is a clear 
risk that these results are underpowered to determine any difference at the 60-minute warming 
timepoint. This is despite accounting for a 25% dropout rate prior to 60 minutes. Failure to achieve 
this threshold is attributed partially to the period of time taken for the ZHF thermometry to calibrate 
after being placed on the participant and the subsequent delay in the placement of warming 
devices.  
In this study, only 60% of participants spent 60 minutes or more in PACU, in hindsight examination of 
the primary endpoint at an earlier timepoint may have been more clinically appropriate. Supporting 
this is the evidence from the planned secondary outcomes analysis of the 10-minute warming 
intervals which indicate no statistical difference throughout the first 60 minutes. In the initial stages 
after warming begins there appears to be a small non statistically significant trend towards improved 
warming with the Orve+ wrap® (Table 2, Figure 3). We believe this is as result of stored heat in the 
blanket acquired from the blanket warmer being transferred to the patient, as this improvement 
appears to plateau at 20 minutes, potentially reflecting when the point at which the Orve+ wrap® 
has lost all its stored heat and primarily works through insulation. 
The selection of a mean difference of 0.3°c as the non-inferiority was chosen based on the accuracy 
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relevant for practitioners to change clinical practice. This is supported by existing data 
demonstrating a 0.5 – 1.0°C higher mean temperature in Forced Air Warming compared with other 
passive warming devices (Alderson et al., 2014).  In practice however, absolute thresholds, alongside 
patients’ clinical or sensorial status are used to initiate warming measures I.e. (temperature <36°C or 
patients feeling cold). In the absence of data on practitioners’ perspectives of clinically relevant 
warming differences and the evidence presented by Alderson et al (2014), it may be that a larger 
inferiority margin would have provided both clinically and statistically convincing findings.   
These results are consistent with historic data using this outcome measure which also showed 
minimal impact of Forced Air Warming after 60 minutes of warming (Summers et al., 1990; Ereth et 
al., 1992). In the absence of a Core Outcome set for this group of patients, the use of this measure as 
a primary outcome may be flawed and alternative measures such as time to normothermia may 
provide more patient focused indicators of blanket performance. In hindsight, on this basis we 
believe that a study with adequate power at 60 minutes, and an appropriate a primary outcome 
measure or non-inferiority margin, it would be likely to demonstrate the Orve+ wrap® non inferiority 
to Forced Air Warming.   
Whilst this study was not powered to identify any changes between the groups with regards to the 
post-operative adverse events; it is reassuring to see comparable incidence in this study. Of note is 
the incidence of surgical site infections (SSI); we used a pragmatic definition to determine the 
presence of SSI; “any non-prophylactic antibiotic use for suspected wound infection prior to hospital 
discharge”.  In both arms there were no surgical site infections during the initial hospital stay. Data 
for England identifies around a 0.6% incidence of SSI for comparable orthopaedic procedures to 
those undertaken in this study, with a median onset date of around 17-20 days (Public Health 
England, 2018). In our study the intra-operative warming methods were not protocolised and a 
mixture of methods were used including Forced Air Warming. With mixed opinions and evidence 
(Kellam, Dieckmann and Austin, 2013) on the use and impact of Forced Air Warming during surgery, 
the decision for its use was at the discretion of the surgeon and anaesthetist. The absence of SSI 
infections in the study is promising, but not surprising based on current SSI rates and an observed 
shorter mean length of stay in this study than the observed median days for onset of SSI in England.   
The prevalence of postoperative hypothermia in this study was 62% which corresponds well with 
previous data (Alderson et al., 2014; Al-Qahtani & Messahel, 2014; Harper et al., 2008). Highlighting 
that despite recent efforts and techniques for pre and intraoperative warming, temperature 
management in the post-operative phase remains as important. In view of current guidance for 
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Orve+wrap® this study focuses on a narrow but clinically relevant temperature window (35.0 - 
35.9°C). Accordingly, these data only reflect patients in the post-operative period, and it is unknown 
how the device would perform on patients presenting with temperatures outside this range or in 
different contexts. 
NICE guidance (NICE, 2016) recommends direct measurement of temperature in the perioperative 
phase, which include distal oesophagus, rectum, urinary bladder and ZHF. To generate the primary 
outcome data for this study ZHF was used to measure temperature in this study. Whilst not widely 
adopted in the UK the use of the 3m Spot On™ probes, ZHF thermometry was based on a growing 
body of evidence describing increased accuracy and reduced variability, compared with other means 
of thermometry, whilst also being an acceptable and risk-free approach in awake patients, NICE, 
2017; Eshraghi et al., 2014; Boisson et al., 2018; Arunachalam, Akehurst and Eitel, 2015). We found 
close agreement between the mean first Spot On™ and tympanic temperature measurements but a 
higher degree of variation in the tympanic measurements. The possibility of a larger variance 
between the two thermometry methods is possible through different temperature ranges and the 
influence of the thermometry equipment on these outcomes should not be underestimated. 
There are several limitations to this study; firstly, we observed a statistically significant longer PACU 
length of stay for the Forced Air Warming group; this may have been due to the extended time taken 
to remove the warming equipment in the Forced Air Warming, however this it is unlikely to explain 
the entire delay. Alternatively, despite randomisation, there may have been non-clinical reasons that 
contributed to delays in PACU discharge that were not controlled for in this study, such as a lack of 
surgical ward beds for patients to be transferred to. This increased mean length of stay may be also 
be related to a number of outliers in the Forced Air Warming group, as the seven longest PACU stays 
were all in patients who had Forced Air Warming. 
Secondly the nature of the interventions resulted in the inability to blind PACU staff to the 
randomization, for this reason we are unable to unequivocally determine that specific outcomes 
have not been influenced by bias, such as the earlier discharge of patients.  The novel and open 
usage of the Orve+wrap® could have led to the possibility of performance bias on the part of the 
nurses caring for patients, where they either consciously or subconsciously were more proactive in 
discharging these patients earlier. This bias may be attributed to the steeper warming trajectory of 
the Orve+wrap® group which primed the PACU nurses for the potential discharge.  
Finally, it also took longer to commence the Forced Air Warming placing the Orve+wrap® on the 
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practicality of delivering Forced Air Warming i.e. locating a warming unit, accessing a suitable power 
source and connecting hoses to blankets, rather than any deliberate delay to start therapy. This is 
reinforced by the higher variability in the mean duration of Forced Air Warming placement, 
suggesting that the Orve+wrap® warming was more straight forward to initiate. The impact of this 
real-world delay of instigating Forced Air Warming is unclear in this study but may have resulted in 
underperformance of the Forced Air Warming. The incorporation of User Acceptability Testing with 
the healthcare professionals in this study for both devices would have helped highlight the 
Orve+wraps’® clinical utility. 
In summary when evaluating against mean patient temperature at 60 minutes, this study 
demonstrates the Orve+wrap’s’® non-inferiority to Forced Air Warming in the post-operative phase 
in conditions described here. Alongside this during the patients’ PACU stay the adverse event rates 
were low and were statistically not significantly different; demonstrating the safety of the 
Orve+wrap® in the post-operative period. The advantages of the Orve+wrap® blankets is that they 
appear to be quick to apply to the patient and that numerous blankets only require a single heat 
source to “charge” with heat. However, their effectiveness without preheating still requires further 
exploration. 
Relevance to clinical practice. 
This study adds useful clinical data to the use of the Orve+wrap® blanket. It provides health care 
practitioners with information on its utility in a post-operative setting and whilst efforts to reduce 
the incidence of intraoperative and subsequent post-operative hypothermia should be prioritised, 
the availability of the Orve+wrap® increases the options available to practitioners in warming and 
keeping patients warm. 
However, recommendations for future explorations of the Orve+wrap® blanket should include the 
efficacy for the whole duration of the peri-operative period, efficacy in different patient populations, 
alongside health economic evaluations, ensuring the device is cost effective compared to other 
patient warming interventions. Additionally, due to its low-tech design, explorations into its use in 
low income countries and those with limited access to reliable electricity sources may provide far 
reaching opportunities for Orve+wrap’s® clinical utility. 
 
What does this paper contribute to the wider global community? 
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 The Orve+wrap® could be used as an alternative intervention to Forced Air Warming in post-
operative warming. 
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Figure 1. Orve+wrap® blanket. 
Figure 2. CONSORT diagram of patient recruitment. 
Figure 3. Mean Temperature at 10-minute intervals from warming device placement with 
Standard Error bars. 
Figure 4. Mean Temperature (°C) differences at 60 minutes, with error bars for two-sided 95% 
Confidence Intervals. The non-inferiority margin is represented by a solid line set at 0.3°C. 
 
Table 1 Characteristics and intraoperative data of patients receiving Orve+wrap® or Forced Air 
Warming. Values are mean or number with SD or proportion in parentheses.  
 Orve+wrap® 
(n = 64) 
Forced Air Warming 
(n = 64) 
Age; (years) 62.6 (14.3) 63.3 (14.2) 
Sex; Male 38 (59%) 28 (44%) 




1.97 (0.24) 1.96 (0.21) 
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Spinal (Yes) 31 (48%) 32 (50%) 
Vasopressors (Yes) 22(34%) 31(48%) 
Ambient Temperature on PACU Arrival (°C) 23.7 (1.4) 23.6 (1.3) 
First Spot On™ Temperature (°C) 35.4 (0.3) 35.5 (0.3) 
First Tympanic Temperature (°C) 35.5 (0.6) 35.5 (0.5) 
Surgery Length (mins) 112.9 (68.0) 119.7 (56.7) 
Anaesthesia Length (mins) 150.4 (77.7) 163.8 (66.7) 
Orthopaedic Surgery 62 (97%) 61 (95%) 
Cardiothoracic Surgery 2 (3%) 3 (5%) 
 
Table 2 Mean Temperature at 10-minute intervals from device placement. Values are displayed as 
Mean (SD) and number 
 Orve+wrap® Forced Air Warming ANCOVA, p-
value 
 Mean (SD), n Mean (SD), n  
First Spot On™ Temperature (°C) 35.4 (0.3), 64 35.5 (0.3), 64 - 
Temperature at 10 minutes (°C) 35.9 (0.4), 63 35.8 (0.4), 64 0.18 
Temperature at 20 minutes (°C) 35.9 (0.4), 61 35.9 (0.4), 64 0.34 
Temperature at 30 minutes (°C) 36.0 (0.4), 58 36.0 (0.5). 62 0.76 
Temperature at 40 minutes (°C) 36.0 (0.5), 51 36.1 (0.4), 56 0.57 
Temperature at 50 minutes (°C) 36.1 (0.5), 40 36.2 (0.5), 40 0.32 
Temperature at 60 minutes (°C) 36.2 (0.6), 30 36.3 (0.5), 32 0.75 
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Arrhythmia 1 0 0.32 
Hypotension 1 2 0.56 
Shivering 6 4 0.51 
Surgical Site 
Infections 
0 0 - 
 
 
Table 4 Length of Stay for patient receiving Orve+wrap® and Forced Air Warming. Values are mean 
with SD in parentheses.  






PACU LOS (mins) 67.3 (22.6) 80.2 (44.4) 12.5 (0.1, 25.0) 0.05 
Post-Surgery Length of Stay (days) 3.1 (2.6) 3.3 (2.4) 0.1 (-0.8, 1.0) 0.64 
 
Table 5 Time taken in minutes to place warming devices for patient receiving Orve+wrap® and 
Forced Air Warming. Values are mean and SD in parentheses. 






PACU Admission to 
Spot On™ Reading  
5:28 (2:02) 06:26 (3:42) 00:48 (00:17, 
01:19) 
0.71 
PACU Admission to 
device placement 
7:16 (2:36) 10:16 (4:04) 02:46 (02:12, 
03:20) 
<0.001 
Spot On™ Reading 
to Device 
Placement 




Table 3 Post-operative Adverse events in between Orve+wrap® and Forced Air Warming patients 
(0.5 level of significance) 
















   
Consented (n=281) Excluded (n=152) 
   Did not have surgery (n=4) 
   Missed in post-operative period (n=6) 
   Not meeting inclusion criteria (n=142) 
• Temperature ≥ 36°C (n=87) 
• Temperature ≤ 34.9°C (n=44) 
• Clinical Team Withdrawal (n=4) 
• Thyroid Dysfunction (n=3) 
• Spot On® Device Failure (n=1) 
• No Spot on® Probes available 
(n=3) 
T10 (n= 63) 
Allocated and received Orve+wrap® (n=65) 
• Excluded from analysis (Retrospective 
identification of exclusion criteria) (n=1) 








Assessed for eligibility (n=503) 
Excluded (n= 222) 
  Not meeting inclusion criteria (n=66) 
  Declined to participate (n=39) 
  No Spot On probes available (n=37) 




T10 (n= 64) 
T60 (n= 32) T60 (n= 30)  
T50 (n= 40) T50 (n= 40) 
T30 (n= 58) T30 (n= 62) 
T20 (n= 61) T20 (n= 64) 
T40 (n= 51) T40 (n= 56) 
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